Literature DB >> 2753954

Isoelectric focusing of cross-linked monoclonal antibody heterodimers, homodimers and derivatized monoclonal antibodies.

D A Bush1, M A Winkler.   

Abstract

Anti-tumor monoclonal antibodies were cross-linked to the anti-CD3 T-cell antibody OKT3 by the use of the heterobifunctional cross-linker succinimidyl-3-(2-pyridyldithio)propionate. Derivatized monoclonal antibodies, heterodimers, and homodimers were resolved by analytical isoelectric focusing in polyacrylamide gels containing 1% Triton X-100. Isoelectric points of the derivatized antibodies were lower than native antibodies, consistent with lysine derivatization. Antibodies derivatized with 2-iminothiolane were equivalent or slightly higher in pI compared with native antibodies. Heterodimers focused in microheterogeneous bands between the pI extremes of the parent derivatized antibodies. The isoelectric points of homodimers were lower than those of parental antibodies and could be distinguished from heterodimers. Reduced and alkylated heterodimers were resolved into their constituent antibodies by isoelectric focusing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753954     DOI: 10.1016/s0378-4347(00)82908-4

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Preparation and analysis of bifunctional immunoconjugates containing monoclonal antibodies OKT3 and BABR1.

Authors:  P D Foglesong; M A Winkler; J O Price; G D Marshall; S H Reagh; D A Bush; K S Hixson; W H West
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  A practical approach to crosslinking.

Authors:  G Mattson; E Conklin; S Desai; G Nielander; M D Savage; S Morgensen
Journal:  Mol Biol Rep       Date:  1993-04       Impact factor: 2.316

3.  Cultured breast cystosarcoma phylloides cells and applications to patient therapy.

Authors:  W M Lewko; R Vaghmar; J R Maleckar; S Husseini; C A Montgomery; G B Thurman; R K Oldham
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.